News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Michael J. Fox Foundation Awards Anida Pharma Research Grant



9/27/2013 10:31:50 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anida Pharma, Inc. announced today that it has been awarded funding by The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to conduct pre-clinical research using its lead compound for treatment of neurodegenerative diseases, Neuroprotectin D1 (NPD1). This is Anida Pharma’s first grant from MJFF. “The grant will not only provide funding but, equally important, will bring Anida into the network of outstanding experts that support MJFF’s mission to accelerate translational research and bring new disease-modifying treatment options to patients with Parkinson’s disease. The collaboration marks a significant step for Anida, and we will be looking forward to building our scientific relationship with the Foundation,” said Per Gjorstrup, MD, PhD, President and CEO of Anida Pharma.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES